New Zealand markets closed

Azul S.A. (AZUL)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
15.09+0.15 (+1.00%)
At close: 04:00PM EST
15.19 +0.10 (+0.66%)
After hours: 07:54PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 1.60B
Enterprise value 5.32B
Trailing P/E 16.74
Forward P/E 47.39
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.84
Price/book (mrq)N/A
Enterprise value/revenue 1.12
Enterprise value/EBITDA -1.79

Trading information

Stock price history

Beta (5Y monthly) 1.73
52-week change 3-26.89%
S&P500 52-week change 314.07%
52-week high 329.45
52-week low 311.31
50-day moving average 313.70
200-day moving average 319.81

Share statistics

Avg vol (3-month) 32.17M
Avg vol (10-day) 32.29M
Shares outstanding 5115.22M
Implied shares outstanding 6N/A
Float 889.18M
% held by insiders 10.00%
% held by institutions 142.16%
Shares short (30 Dec 2021) 49.21M
Short ratio (30 Dec 2021) 44.44
Short % of float (30 Dec 2021) 4N/A
Short % of shares outstanding (30 Dec 2021) 47.99%
Shares short (prior month 29 Nov 2021) 49.69M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in BRL.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin -51.85%
Operating margin (ttm)-21.82%

Management effectiveness

Return on assets (ttm)-6.87%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)7.98B
Revenue per share (ttm)69.45
Quarterly revenue growth (yoy)237.50%
Gross profit (ttm)-472.12M
Net income avi to common (ttm)-4.14B
Diluted EPS (ttm)-6.64
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.63B
Total cash per share (mrq)31.53
Total debt (mrq)24.79B
Total debt/equity (mrq)N/A
Current ratio (mrq)0.59
Book value per share (mrq)-155.67

Cash flow statement

Operating cash flow (ttm)-431.49M
Levered free cash flow (ttm)-3.57B